NCT03782987View on ClinicalTrials.gov

A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 730357 in the Blood

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

January 10, 2019

Primary Completion Date

March 11, 2019

Study Completion Date

March 11, 2019

Conditions
Healthy
Interventions
DRUG

BI 730357

0 mg BI 730357 tablet orally on Day 1

DRUG

Itraconazole

20 mL of 10 mg/ mL Itraconazole oral solution in treatment period 2 only (T). Itraconazole was administered once daily for 12 days from Day -3 to Day 9.

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY